Resveratrol Protects DAergic PC12 Cells from High Glucose-Induced Oxidative Stress and Apoptosis: Effect on p53 and GRP75 Localization

• Published in: Neurotoxicity research Vol. 25; no. 1; pp. 110 - 123
• Main Authors: Renaud, Justine, Bournival, Julie, Zottig, Ximena, Martinoli, Maria-Grazia
• Format: Journal Article
• Language: English
• Published: Boston Springer US 01.01.2014
• Subjects: Animals; Antioxidants; Antioxidants - pharmacology; Apoptosis - drug effects; Biomedical and Life Sciences; Biomedicine; Cell Biology; Cells, Cultured; Dopaminergic Neurons - drug effects; Dopaminergic Neurons - metabolism; Glucose - toxicity; HSP70 Heat-Shock Proteins - metabolism; Membrane Proteins - metabolism; Neurobiology; Neurochemistry; Neurology; Neurosciences; Original; Original Article; Oxidative Stress - drug effects; PC12 Cells; Pharmacology/Toxicology; Rats; Stilbenes - pharmacology; Superoxides - metabolism; Tumor Suppressor Protein p53 - metabolism; Oxidative stress; Neuroprotection; GRP75; Resveratrol; High glucose; Apoptosis
• ISSN: 1029-8428; 1476-3524
• DOI: 10.1007/s12640-013-9439-7

Resveratrol (RESV), a polyphenolic natural compound, has long been acknowledged to have cardioprotective and antiinflammatory actions. Evidence suggests that RESV has antioxidant properties that reduce the formation of reactive oxygen species leading to oxidative stress and apoptotic death of dopaminergic (DAergic) neurons in Parkinson’s disease (PD). Recent literature has recognized hyperglycemia as a cause of oxidative stress reported to be harmful for the nervous system. In this context, our study aimed (a) to evaluate the effect of RESV against high glucose (HG)-induced oxidative stress in DAergic neurons, (b) to study the antiapoptotic properties of RESV in HG condition, and c) to analyze RESV’s ability to modulate p53 and GRP75, a p53 inactivator found to be under expressed in postmortem PD brains. Our results suggest that RESV protects DAergic neurons against HG-induced oxidative stress by diminishing cellular levels of superoxide anion. Moreover, RESV significantly reduces HG-induced apoptosis in DAergic cells by modulating DNA fragmentation and the expression of several genes implicated in the apoptotic cascade, such as Bax, Bcl-2, cleaved caspase-3, and cleaved PARP-1. RESV also prevents the pro-apoptotic increase of p53 in the nucleus induced by HG. Such data strengthens the correlation between hyperglycemia and neurodegeneration, while providing new insight on the high occurrence of PD in patients with diabetes. This study enlightens potent neuroprotective roles for RESV that should be considered as a nutritional recommendation for preventive and/or complementary therapies in controlling neurodegenerative complications in diabetes.